These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy. McIntyre C; McQuillan R; Bell C; Battistella M Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321 [TBL] [Abstract][Full Text] [Related]
23. Issues with deprescribing in haemodialysis: a qualitative study of patient and provider experiences. Bondurant-David K; Dang S; Levy S; Sperlea D; Vanier MC; Gerardi S; David PM Int J Pharm Pract; 2020 Dec; 28(6):635-642. PubMed ID: 33094884 [TBL] [Abstract][Full Text] [Related]
24. [MEDICATIONS DEPRESCRIBING IN ELDERLY NURSING HOME RESIDENTS]. Aizen E; Hindawil E; Hijazi M; Merih A; Shahla H; Elyounes AA Harefuah; 2016 Mar; 155(3):145-9, 197. PubMed ID: 27305746 [TBL] [Abstract][Full Text] [Related]
25. The effects of in-hospital deprescribing on potential prescribing omission in hospitalized elderly patients with polypharmacy. Kaminaga M; Komagamine J; Tatsumi S Sci Rep; 2021 Apr; 11(1):8898. PubMed ID: 33903645 [TBL] [Abstract][Full Text] [Related]
26. Optimising Medications for Patients With Cancer and Multimorbidity: The Case for Deprescribing. Turner JP; Kantilal K; Kantilal K; Holmes HM; Koczwara B Clin Oncol (R Coll Radiol); 2020 Sep; 32(9):609-617. PubMed ID: 32563549 [TBL] [Abstract][Full Text] [Related]
27. The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people. Todd A; Jansen J; Colvin J; McLachlan AJ BMC Geriatr; 2018 Nov; 18(1):295. PubMed ID: 30497404 [TBL] [Abstract][Full Text] [Related]
28. Community-dwelling older people's attitudes towards deprescribing in Canada. Sirois C; Ouellet N; Reeve E Res Social Adm Pharm; 2017; 13(4):864-870. PubMed ID: 27663392 [TBL] [Abstract][Full Text] [Related]
29. Drug Prescribing: Polypharmacy and Deprescribing. McQuade BM; Campbell A FP Essent; 2021 Sep; 508():33-40. PubMed ID: 34491710 [TBL] [Abstract][Full Text] [Related]
30. Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older: The OPTIMISE Randomized Clinical Trial. Sheppard JP; Burt J; Lown M; Temple E; Lowe R; Fraser R; Allen J; Ford GA; Heneghan C; Hobbs FDR; Jowett S; Kodabuckus S; Little P; Mant J; Mollison J; Payne RA; Williams M; Yu LM; McManus RJ; JAMA; 2020 May; 323(20):2039-2051. PubMed ID: 32453368 [TBL] [Abstract][Full Text] [Related]
31. The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial. Bayliss EA; Shetterly SM; Drace ML; Norton J; Green AR; Reeve E; Weffald LA; Wright L; Maciejewski ML; Sheehan OC; Wolff JL; Gleason KS; Kraus C; Maiyani M; Du Vall M; Boyd CM Trials; 2020 Jun; 21(1):542. PubMed ID: 32552857 [TBL] [Abstract][Full Text] [Related]
32. Implementing a Proactive Deprescribing Approach to Prevent Adverse Drug Events. Anderson TS; Goyal P; Marcum ZA J Gen Intern Med; 2020 Dec; 35(12):3694-3696. PubMed ID: 32410126 [No Abstract] [Full Text] [Related]
33. New horizons in deprescribing for older people. Woodford HJ; Fisher J Age Ageing; 2019 Nov; 48(6):768-775. PubMed ID: 31595290 [TBL] [Abstract][Full Text] [Related]
34. Deprescribing trials: A focus on adverse drug withdrawal events. Hanlon JT; Gray SL J Am Geriatr Soc; 2022 Sep; 70(9):2738-2741. PubMed ID: 35596673 [No Abstract] [Full Text] [Related]
35. Chronic Polypharmacy with Increasing Drug Burden Index Exacerbates Frailty and Impairs Physical Function, with Effects Attenuated by Deprescribing, in Aged Mice. Mach J; Gemikonakli G; Logan C; Vander Wyk B; Allore H; Ekambareshwar S; Kane AE; Howlett SE; de Cabo R; Le Couteur DG; Hilmer SN J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1010-1018. PubMed ID: 32147704 [TBL] [Abstract][Full Text] [Related]
36. Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study. Komagamine J; Sugawara K; Hagane K BMC Geriatr; 2018 Apr; 18(1):96. PubMed ID: 29665778 [TBL] [Abstract][Full Text] [Related]
37. The Role of Deprescribing in Older Adults with Chronic Kidney Disease. Triantafylidis LK; Hawley CE; Perry LP; Paik JM Drugs Aging; 2018 Nov; 35(11):973-984. PubMed ID: 30284120 [TBL] [Abstract][Full Text] [Related]
38. Deprescribing of non-antiretroviral therapy in HIV-infected patients. Blanco JR; Morillo R; Abril V; Escobar I; Bernal E; Folguera C; Brañas F; Gimeno M; Ibarra O; Iribarren JA; Lázaro A; Mariño A; Martín MT; Martinez E; Ortega L; Olalla J; Robustillo A; Sanchez-Conde M; Rodriguez MA; de la Torre J; Sanchez-Rubio J; Tuset M; Eur J Clin Pharmacol; 2020 Mar; 76(3):305-318. PubMed ID: 31865412 [TBL] [Abstract][Full Text] [Related]
39. Appropriate deprescribing in older people: a challenging necessityCommentary to accompany themed collection on deprescribing. van der Velde N; Minhas JS Age Ageing; 2021 Sep; 50(5):1516-1519. PubMed ID: 34260681 [TBL] [Abstract][Full Text] [Related]
40. An Ecological Approach to Reducing Potentially Inappropriate Medication Use: Canadian Deprescribing Network. Tannenbaum C; Farrell B; Shaw J; Morgan S; Trimble J; Currie J; Turner J; Rochon P; Silvius J Can J Aging; 2017 Mar; 36(1):97-107. PubMed ID: 28091333 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]